Quantcast
Last updated on April 20, 2014 at 5:20 EDT

Latest Low-density lipoprotein Stories

2013-11-25 16:26:32

DUBLIN, November 25, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/559pr8/pcsk9_inhibitors) has announced the addition of the "PCSK9 Inhibitors - The hot new approach to lower cholesterol" [http://www.researchandmarkets.com/research/559pr8/pcsk9_inhibitors ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Several companies are actively pursuing a new strategy to lower cholesterol: the...

2013-11-25 08:28:16

RALEIGH, N.C., Nov. 25, 2013 /PRNewswire/ -- LipoScience, Inc. (NASDAQ: LPDX), a diagnostic company pioneering a new field of personalized nuclear magnetic resonance (NMR) diagnostics to advance the quality of patient care in cardiovascular, metabolic and other diseases, today announced an agreement to place the Vantera(®) Clinical Analyzer within Scripps Health facilities. The agreement, which marks the first placement of the Vantera Clinical Analyzer in the state of California,...

2013-11-24 23:00:17

Crunch Cholesterol designed by Colin Carmichael is a new book that covers detailed instructions on how to reduce high cholesterol levels effortlessly. A detailed Crunch Cholesterol overview on the site Vkoolelite indicates if this book is worth buying. Seattle, Wa (PRWEB) November 24, 2013 Cholesterol is a type of fat (lipid) in their blood. If people have too much cholesterol, it starts to build up in their arteries (blood vessels). The buildup of cholesterol narrows their arteries and...

2013-11-19 20:21:30

Data Presented at American Heart Association Scientific Sessions 2013 and Simultaneously Published in Circulation THOUSAND OAKS, Calif., Nov. 19, 2013 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced results from the Open Label Study of Long TERm Evaluation Against LDL-C (OSLER) trial, a long-term controlled 52-week safety and efficacy study, that showed monthly treatment with evolocumab (AMG 145), an investigational fully human monoclonal antibody that inhibits PCSK9, a protein that...

2013-11-18 20:44:39

Seth S. Martin, M.D., of the Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Baltimore, and colleagues developed a method for estimating low-density lipoprotein cholesterol (LDL-C) levels that is more accurate than the standard measure. Low-density lipoprotein cholesterol is the primary target for treatment in national and international clinical practice guidelines. Conventionally, LDL-C is estimated by the Friedewald equation, which estimates LDL-C as (total...

2013-11-18 20:38:54

Findings follow previous study showing that commonly used equation underestimates heart disease danger for many at high risk Johns Hopkins researchers have developed a more accurate way to calculate low-density lipoprotein (LDL) cholesterol, the so-called "bad" form of blood fat that can lead to hardening of the arteries and increase the risk of heart attack and stroke. If confirmed and adopted by medical laboratories that routinely calculate blood cholesterol for patients, the researchers...

2013-11-18 20:21:13

- Data presented today at the American Heart Association CARLSBAD, Calif., Nov. 18, 2013 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced new results from its Phase 2 study of ISIS-APOCIII(Rx) as a monotherapy in patients with very high to severely high triglycerides. These new data and an overall summary of the Phase 2 program for ISIS-APOCIII(Rx) were presented today by Dr. Rosanne Crooke at the American Heart Association Scientific Sessions in Dallas. In...

2013-11-18 12:29:41

RALEIGH, N.C., Nov. 18, 2013 /PRNewswire/ -- LipoScience, Inc. (NASDAQ: LPDX), a diagnostic company pioneering a new field of personalized nuclear magnetic resonance (NMR) diagnostics to advance the quality of patient care in cardiovascular, metabolic and other diseases, today announced that low-density lipoprotein particle (LDL-P) number can predict cardiovascular events independently of LDL cholesterol (LDL-C) concentrations in a real-world environment, as presented in a poster session at...

2013-11-17 23:01:04

A new article released on the site Healthreviewcenter.com offers 10 natural ways to lower cholesterol. Seattle, Wa (PRWEB) November 17, 2013 The article on the site Healthreviewcenter.com introduces 10 natural ways to lower cholesterol. This article is useful for people who want to learn the truth about cholesterol and how to reduce cholesterol level quickly. Firstly, the writer indicates that people should drink alcohol in moderation because drinking excessively will lead to many health...

2013-11-16 16:20:30

CARLSBAD, Calif., Nov. 16, 2013 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today positive results from a Phase 1 study with ISIS-APO(a)(Rx). These data were presented by Dr. Sotirios Tsimikas at the Vascular Biology Working Group global chapter meeting occurring concurrently with the American Heart Association (AHA) in Dallas, Texas. These data will also be presented at the AHA on Sunday, November 17 at 3:00 p.m. Central Time in the poster session titled...